Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.
Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.
艾裏德克斯發佈了經同行評審的研究，關於眼科醫療治療；強調了微脈衝鞏膜激光治療在管理原發性和繼發性青光眼方面的安全性和有效性，歷時五年。
Iridex Publishes Peer-Reviewed Study In Ophthalmology Therapy; Highlights Safety And Efficacy Of MicroPulse Transscleral Laser Therapy In Managing Both Primary And Secondary Glaucoma Over Five Years.
艾裏德克斯發佈了經同行評審的研究，關於眼科醫療治療；強調了微脈衝鞏膜激光治療在管理原發性和繼發性青光眼方面的安全性和有效性，歷時五年。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間